ES2659469T3 - Método para detectar e identificar Escherichia Coli enterohemorrágica - Google Patents

Método para detectar e identificar Escherichia Coli enterohemorrágica Download PDF

Info

Publication number: ES2659469T3
Authority: ES; Spain
Prior art keywords: eceh; primers; seq; crispr; sequence
Prior art date: 2012-06-14
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

ES13747516.6T

Other languages

English (en)

Spanish (es)

Inventor

Patrick Fach

Sabine Delannoy

Lothar Beutin

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Bundesinstitut fur Risikobewertung

BUNDESINSTITUT fur RISIKOBEWERTUNG

Agence National de Securite Sanitaire de l'Alimentation de l'Environnement Et du Travail

Original Assignee

Bundesinstitut fur Risikobewertung

BUNDESINSTITUT fur RISIKOBEWERTUNG

Agence National de Securite Sanitaire de l'Alimentation de l'Environnement Et du Travail

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-06-14

Filing date

2013-06-14

Publication date

2018-03-15

2013-06-14 Application filed by Bundesinstitut fur Risikobewertung, BUNDESINSTITUT fur RISIKOBEWERTUNG, Agence National de Securite Sanitaire de l'Alimentation de l'Environnement Et du Travail filed Critical Bundesinstitut fur Risikobewertung

2018-03-15 Application granted granted Critical

2018-03-15 Publication of ES2659469T3 publication Critical patent/ES2659469T3/es

Status Active legal-status Critical Current

2033-06-14 Anticipated expiration legal-status Critical

Links

241000588724 Escherichia coli Species 0.000 title claims abstract description 125
238000000034 method Methods 0.000 title claims abstract description 41
108091033409 CRISPR Proteins 0.000 claims abstract description 136
238000010354 CRISPR gene editing Methods 0.000 claims abstract description 135
108020004414 DNA Proteins 0.000 claims abstract description 19
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims abstract description 7
101150082166 espK gene Proteins 0.000 claims description 137
239000000523 sample Substances 0.000 claims description 94
230000003321 amplification Effects 0.000 claims description 85
238000003199 nucleic acid amplification method Methods 0.000 claims description 85
238000001514 detection method Methods 0.000 claims description 74
101100021923 Helicobacter pylori (strain ATCC 700392 / 26695) lspA gene Proteins 0.000 claims description 48
101150070667 ureD gene Proteins 0.000 claims description 48
238000002944 PCR assay Methods 0.000 claims description 41
108090000623 proteins and genes Proteins 0.000 claims description 30
239000013615 primer Substances 0.000 description 111
230000002068 genetic effect Effects 0.000 description 59
230000001717 pathogenic effect Effects 0.000 description 26
108010079723 Shiga Toxin Proteins 0.000 description 24
101150107911 eae gene Proteins 0.000 description 21
230000035945 sensitivity Effects 0.000 description 19
101100500479 Hafnia alvei eaeA gene Proteins 0.000 description 18
238000003753 real-time PCR Methods 0.000 description 16
238000009826 distribution Methods 0.000 description 14
230000001018 virulence Effects 0.000 description 12
-1 phages or plasmids Chemical class 0.000 description 11
230000037029 cross reaction Effects 0.000 description 10
108091028043 Nucleic acid sequence Proteins 0.000 description 9
235000013305 food Nutrition 0.000 description 9
241000282412 Homo Species 0.000 description 8
238000006243 chemical reaction Methods 0.000 description 8
208000015181 infectious disease Diseases 0.000 description 8
239000003550 marker Substances 0.000 description 7
102000004169 proteins and genes Human genes 0.000 description 7
238000012360 testing method Methods 0.000 description 7
201000010099 disease Diseases 0.000 description 6
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
230000036541 health Effects 0.000 description 6
239000002987 primer (paints) Substances 0.000 description 6
238000012163 sequencing technique Methods 0.000 description 6
238000003556 assay Methods 0.000 description 5
208000032759 Hemolytic-Uremic Syndrome Diseases 0.000 description 4
125000006850 spacer group Chemical group 0.000 description 4
102000053602 DNA Human genes 0.000 description 3
101100001161 Escherichia coli aggR gene Proteins 0.000 description 3
230000001580 bacterial effect Effects 0.000 description 3
239000012636 effector Substances 0.000 description 3
238000005516 engineering process Methods 0.000 description 3
230000000369 enteropathogenic effect Effects 0.000 description 3
239000000463 material Substances 0.000 description 3
239000000203 mixture Substances 0.000 description 3
238000011002 quantification Methods 0.000 description 3
241000894006 Bacteria Species 0.000 description 2
238000001712 DNA sequencing Methods 0.000 description 2
206010012735 Diarrhoea Diseases 0.000 description 2
206010014896 Enterocolitis haemorrhagic Diseases 0.000 description 2
238000007397 LAMP assay Methods 0.000 description 2
101150000110 Nle gene Proteins 0.000 description 2
238000012408 PCR amplification Methods 0.000 description 2
238000011529 RT qPCR Methods 0.000 description 2
108010017898 Shiga Toxins Proteins 0.000 description 2
108010046334 Urease Proteins 0.000 description 2
238000004458 analytical method Methods 0.000 description 2
239000000427 antigen Substances 0.000 description 2
108091007433 antigens Proteins 0.000 description 2
102000036639 antigens Human genes 0.000 description 2
239000003153 chemical reaction reagent Substances 0.000 description 2
238000003745 diagnosis Methods 0.000 description 2
230000007613 environmental effect Effects 0.000 description 2
230000002550 fecal effect Effects 0.000 description 2
239000007850 fluorescent dye Substances 0.000 description 2
238000011835 investigation Methods 0.000 description 2
150000007523 nucleic acids Chemical class 0.000 description 2
230000007918 pathogenicity Effects 0.000 description 2
239000013612 plasmid Substances 0.000 description 2
238000003752 polymerase chain reaction Methods 0.000 description 2
238000011895 specific detection Methods 0.000 description 2
230000008685 targeting Effects 0.000 description 2
WCKQPPQRFNHPRJ-UHFFFAOYSA-N 4-[[4-(dimethylamino)phenyl]diazenyl]benzoic acid Chemical compound C1=CC(N(C)C)=CC=C1N=NC1=CC=C(C(O)=O)C=C1 WCKQPPQRFNHPRJ-UHFFFAOYSA-N 0.000 description 1
COCMHKNAGZHBDZ-UHFFFAOYSA-N 4-carboxy-3-[3-(dimethylamino)-6-dimethylazaniumylidenexanthen-9-yl]benzoate Chemical compound C=12C=CC(=[N+](C)C)C=C2OC2=CC(N(C)C)=CC=C2C=1C1=CC(C([O-])=O)=CC=C1C(O)=O COCMHKNAGZHBDZ-UHFFFAOYSA-N 0.000 description 1
WQZIDRAQTRIQDX-UHFFFAOYSA-N 6-carboxy-x-rhodamine Chemical compound OC(=O)C1=CC=C(C([O-])=O)C=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 WQZIDRAQTRIQDX-UHFFFAOYSA-N 0.000 description 1
BZTDTCNHAFUJOG-UHFFFAOYSA-N 6-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=CC=C(C(=O)O)C=C21 BZTDTCNHAFUJOG-UHFFFAOYSA-N 0.000 description 1
108091093088 Amplicon Proteins 0.000 description 1
244000135860 Capparis spinosa subsp spinosa Species 0.000 description 1
101100516697 Citrobacter rodentium nleB gene Proteins 0.000 description 1
108020004635 Complementary DNA Proteins 0.000 description 1
108020001019 DNA Primers Proteins 0.000 description 1
239000003155 DNA primer Substances 0.000 description 1
239000003298 DNA probe Substances 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
241000059459 Escherichia coli O104 Species 0.000 description 1
241001036088 Escherichia coli O104:H4 Species 0.000 description 1
101100240631 Escherichia coli O127:H6 (strain E2348/69 / EPEC) nleB1 gene Proteins 0.000 description 1
241001646719 Escherichia coli O157:H7 Species 0.000 description 1
241000010756 Escherichia coli O157:H7 str. EDL933 Species 0.000 description 1
208000019331 Foodborne disease Diseases 0.000 description 1
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
108010052285 Membrane Proteins Proteins 0.000 description 1
108020005187 Oligonucleotide Probes Proteins 0.000 description 1
238000010222 PCR analysis Methods 0.000 description 1
108091081062 Repeated sequence (DNA) Proteins 0.000 description 1
241000607142 Salmonella Species 0.000 description 1
230000004520 agglutination Effects 0.000 description 1
230000002547 anomalous effect Effects 0.000 description 1
101150117498 arcA gene Proteins 0.000 description 1
230000000712 assembly Effects 0.000 description 1
238000000429 assembly Methods 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
238000010804 cDNA synthesis Methods 0.000 description 1
244000309466 calf Species 0.000 description 1
239000000969 carrier Substances 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
230000002759 chromosomal effect Effects 0.000 description 1
108010056602 colicin immunity proteins Proteins 0.000 description 1
239000002299 complementary DNA Substances 0.000 description 1
238000011109 contamination Methods 0.000 description 1
238000001816 cooling Methods 0.000 description 1
230000009260 cross reactivity Effects 0.000 description 1
238000012217 deletion Methods 0.000 description 1
230000037430 deletion Effects 0.000 description 1
238000013461 design Methods 0.000 description 1
230000009977 dual effect Effects 0.000 description 1
230000000694 effects Effects 0.000 description 1
210000001842 enterocyte Anatomy 0.000 description 1
239000012634 fragment Substances 0.000 description 1
238000012268 genome sequencing Methods 0.000 description 1
230000005802 health problem Effects 0.000 description 1
230000002008 hemorrhagic effect Effects 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
238000007689 inspection Methods 0.000 description 1
210000000936 intestine Anatomy 0.000 description 1
239000003446 ligand Substances 0.000 description 1
239000007788 liquid Substances 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
108020004707 nucleic acids Proteins 0.000 description 1
102000039446 nucleic acids Human genes 0.000 description 1
239000002751 oligonucleotide probe Substances 0.000 description 1
230000002688 persistence Effects 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
230000005180 public health Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
238000012502 risk assessment Methods 0.000 description 1
238000011896 sensitive detection Methods 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
239000002689 soil Substances 0.000 description 1
241000894007 species Species 0.000 description 1
101150080727 stx gene Proteins 0.000 description 1
239000000126 substance Substances 0.000 description 1
239000000758 substrate Substances 0.000 description 1
ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 description 1
239000002699 waste material Substances 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
238000012070 whole genome sequencing analysis Methods 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
- C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
- C12Q2537/143—Multiplexing, i.e. use of multiple primers or probes in a single reaction, usually for simultaneously analyse of multiple analysis
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays

Landscapes

Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Analytical Chemistry (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Biophysics (AREA)
Immunology (AREA)
Microbiology (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Physics & Mathematics (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Chemical Kinetics & Catalysis (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

ES13747516.6T 2012-06-14 2013-06-14 Método para detectar e identificar Escherichia Coli enterohemorrágica Active ES2659469T3 (es)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP12171941.3A EP2674501A1 (en)	2012-06-14	2012-06-14	Method for detecting and identifying enterohemorrhagic Escherichia coli
EP12171941		2012-06-14
PCT/IB2013/054888 WO2013186754A2 (en)	2012-06-14	2013-06-14	Method for detecting and identifying enterohemorrhagic escherichia coli

Publications (1)

Publication Number	Publication Date
ES2659469T3 true ES2659469T3 (es)	2018-03-15

Family

ID=48949190

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ES13747516.6T Active ES2659469T3 (es)	2012-06-14	2013-06-14	Método para detectar e identificar Escherichia Coli enterohemorrágica

Country Status (12)

Country	Link
US (1)	US10190175B2 (2)
EP (2)	EP2674501A1 (2)
JP (1)	JP6166365B2 (2)
KR (1)	KR102065053B1 (2)
CN (1)	CN104619860B (2)
AU (1)	AU2013276084B2 (2)
BR (1)	BR112014031370B1 (2)
CA (1)	CA2875919C (2)
CL (1)	CL2014003377A1 (2)
ES (1)	ES2659469T3 (2)
MX (1)	MX357697B (2)
WO (1)	WO2013186754A2 (2)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US10323236B2 (en)	2011-07-22	2019-06-18	President And Fellows Of Harvard College	Evaluation and improvement of nuclease cleavage specificity
GB201122458D0 (en)	2011-12-30	2012-02-08	Univ Wageningen	Modified cascade ribonucleoproteins and uses thereof
AU2013266968B2 (en)	2012-05-25	2017-06-29	Emmanuelle CHARPENTIER	Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
PL3360964T3 (pl)	2012-12-06	2020-03-31	Sigma-Aldrich Co. Llc	Modyfikacja i regulacja genomu oparta na crispr
RU2662932C2 (ru)	2013-03-14	2018-07-31	Карибо Биосайенсиз, Инк.	Композиции и способы с участием нуклеиновых кислот, нацеленных на нуклеиновые кислоты
US10760064B2 (en)	2013-03-15	2020-09-01	The General Hospital Corporation	RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci
WO2014204578A1 (en)	2013-06-21	2014-12-24	The General Hospital Corporation	Using rna-guided foki nucleases (rfns) to increase specificity for rna-guided genome editing
CN112301024A (zh)	2013-03-15	2021-02-02	通用医疗公司	使用RNA引导的FokI核酸酶(RFN)提高RNA引导的基因组编辑的特异性
US9163284B2 (en)	2013-08-09	2015-10-20	President And Fellows Of Harvard College	Methods for identifying a target site of a Cas9 nuclease
US9526784B2 (en)	2013-09-06	2016-12-27	President And Fellows Of Harvard College	Delivery system for functional nucleases
US9228207B2 (en)	2013-09-06	2016-01-05	President And Fellows Of Harvard College	Switchable gRNAs comprising aptamers
US9322037B2 (en)	2013-09-06	2016-04-26	President And Fellows Of Harvard College	Cas9-FokI fusion proteins and uses thereof
CN106459995B (zh)	2013-11-07	2020-02-21	爱迪塔斯医药有限公司	使用统治型gRNA的CRISPR相关方法和组合物
US20150165054A1 (en)	2013-12-12	2015-06-18	President And Fellows Of Harvard College	Methods for correcting caspase-9 point mutations
US10077453B2 (en)	2014-07-30	2018-09-18	President And Fellows Of Harvard College	CAS9 proteins including ligand-dependent inteins
US10920285B2 (en)	2014-12-03	2021-02-16	Qiagen Gmbh	Highly specific and sensitive methods for detecting enterohemorrhagic Escherichia coli serotypes O157:H7 and/or O145:H28
WO2016115441A1 (en) *	2015-01-16	2016-07-21	Kansas State University Research Foundation	Co-detection and association of multiple genes from the same genome in a sample
US9926546B2 (en)	2015-08-28	2018-03-27	The General Hospital Corporation	Engineered CRISPR-Cas9 nucleases
US9512446B1 (en)	2015-08-28	2016-12-06	The General Hospital Corporation	Engineered CRISPR-Cas9 nucleases
JP6799586B2 (ja)	2015-08-28	2020-12-16	ザジェネラルホスピタルコーポレイション	遺伝子操作ＣＲＩＳＰＲ−Ｃａｓ９ヌクレアーゼ
IL310721B2 (en)	2015-10-23	2025-11-01	Harvard College	Nucleobase editors and uses thereof
CN105779584A (zh) *	2015-12-18	2016-07-20	珠海出入境检验检疫局检验检疫技术中心	大肠杆菌o111检测用的引物和探针组、试剂盒及pcr检测方法
CN105821124A (zh) *	2016-04-06	2016-08-03	山东省滨州畜牧兽医研究院	一种大肠杆菌 o26、o45、o121血清型三重pcr检测试剂盒及其引物组
CN110214183A (zh)	2016-08-03	2019-09-06	哈佛大学的校长及成员们	腺苷核碱基编辑器及其用途
WO2018031683A1 (en)	2016-08-09	2018-02-15	President And Fellows Of Harvard College	Programmable cas9-recombinase fusion proteins and uses thereof
US11542509B2 (en)	2016-08-24	2023-01-03	President And Fellows Of Harvard College	Incorporation of unnatural amino acids into proteins using base editing
KR102622411B1 (ko)	2016-10-14	2024-01-10	프레지던트 앤드 펠로우즈 오브 하바드 칼리지	핵염기 에디터의 aav 전달
WO2018119359A1 (en)	2016-12-23	2018-06-28	President And Fellows Of Harvard College	Editing of ccr5 receptor gene to protect against hiv infection
EP3592853A1 (en)	2017-03-09	2020-01-15	President and Fellows of Harvard College	Suppression of pain by gene editing
US12390514B2 (en)	2017-03-09	2025-08-19	President And Fellows Of Harvard College	Cancer vaccine
US11542496B2 (en)	2017-03-10	2023-01-03	President And Fellows Of Harvard College	Cytosine to guanine base editor
KR20240116572A (ko)	2017-03-23	2024-07-29	프레지던트 앤드 펠로우즈 오브 하바드 칼리지	핵산 프로그램가능한 dna 결합 단백질을 포함하는 핵염기 편집제
US11591589B2 (en)	2017-04-21	2023-02-28	The General Hospital Corporation	Variants of Cpf1 (Cas12a) with altered PAM specificity
US11560566B2 (en)	2017-05-12	2023-01-24	President And Fellows Of Harvard College	Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation
EP3630849A4 (en)	2017-05-25	2021-01-13	The General Hospital Corporation	BIPARTITE BASIC EDITOR (BBE) AND TYPE II-C-CAS9 ZINC FINGER EDITOR ARCHITECTURES
CN111801345A (zh)	2017-07-28	2020-10-20	哈佛大学的校长及成员们	使用噬菌体辅助连续进化(pace)的进化碱基编辑器的方法和组合物
EP3676376B1 (en)	2017-08-30	2025-01-15	President and Fellows of Harvard College	High efficiency base editors comprising gam
KR20250107288A (ko)	2017-10-16	2025-07-11	더 브로드 인스티튜트, 인코퍼레이티드	아데노신 염기 편집제의 용도
US12406749B2 (en)	2017-12-15	2025-09-02	The Broad Institute, Inc.	Systems and methods for predicting repair outcomes in genetic engineering
EP3731959B1 (en) *	2017-12-29	2025-10-08	Clear Labs, Inc.	Automated priming and library loading device
US10597714B2 (en)	2017-12-29	2020-03-24	Clear Labs, Inc.	Automated priming and library loading device
US10246704B1 (en)	2017-12-29	2019-04-02	Clear Labs, Inc.	Detection of microorganisms in food samples and food processing facilities
US12157760B2 (en)	2018-05-23	2024-12-03	The Broad Institute, Inc.	Base editors and uses thereof
US12522807B2 (en)	2018-07-09	2026-01-13	The Broad Institute, Inc.	RNA programmable epigenetic RNA modifiers and uses thereof
CN108950033B (zh) *	2018-07-26	2022-01-11	江苏省农业科学院	同时检测肠出血性大肠杆菌o45和o145的纳米pcr试剂盒及其应用
EP3847277B1 (en) *	2018-09-06	2024-12-11	Hygiena, LLC	Sequences and their use for detection and characterization of escherichia coli serotype o157:h7
CN111100862B (zh) *	2018-10-26	2023-09-29	厦门大学	一种检测细菌血清型的方法
WO2020092453A1 (en)	2018-10-29	2020-05-07	The Broad Institute, Inc.	Nucleobase editors comprising geocas9 and uses thereof
US12351837B2 (en)	2019-01-23	2025-07-08	The Broad Institute, Inc.	Supernegatively charged proteins and uses thereof
US11946040B2 (en)	2019-02-04	2024-04-02	The General Hospital Corporation	Adenine DNA base editor variants with reduced off-target RNA editing
WO2020191233A1 (en)	2019-03-19	2020-09-24	The Broad Institute, Inc.	Methods and compositions for editing nucleotide sequences
US12473543B2 (en)	2019-04-17	2025-11-18	The Broad Institute, Inc.	Adenine base editors with reduced off-target effects
US12435330B2 (en)	2019-10-10	2025-10-07	The Broad Institute, Inc.	Methods and compositions for prime editing RNA
IL297761A (en)	2020-05-08	2022-12-01	Broad Inst Inc	Methods and compositions for simultaneously editing two helices of a designated double-helix nucleotide sequence
US20230279442A1 (en)	2021-12-15	2023-09-07	Versitech Limited	Engineered cas9-nucleases and method of use thereof
CN116903710B (zh) *	2023-09-12	2023-11-14	山东省农业科学院畜牧兽医研究所	噬菌体靶向蛋白分子及其在鉴定o103抗原血清型的产志贺毒素大肠杆菌中的应用
WO2026006542A2 (en)	2024-06-26	2026-01-02	Yale University	Compositions and methods for crispr/cas9 based reactivation of human angelman syndrome

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2002355074A (ja) *	2001-01-24	2002-12-10	Univ Tsukuba	腸管出血性病原性大腸菌ｏ１５７：ｈ７に特異的な核酸分子およびポリペプチド並びにこれらの使用方法
US20060051751A1 (en) *	2002-01-23	2006-03-09	Gehua Wang	Major virulence factor detection and verocytontoxin type 2 subtype from clinical e. coli isolates using a one-step multiplex pcr
EP2292799A1 (en) *	2009-08-11	2011-03-09	Agence Française de Securité Sanitaire des Aliments	An assay for determining a molecular risk assessment of stec isolates

2012
- 2012-06-14 EP EP12171941.3A patent/EP2674501A1/en not_active Withdrawn
2013
- 2013-06-14 JP JP2015516741A patent/JP6166365B2/ja active Active
- 2013-06-14 CN CN201380030965.9A patent/CN104619860B/zh active Active
- 2013-06-14 US US14/407,884 patent/US10190175B2/en active Active
- 2013-06-14 EP EP13747516.6A patent/EP2861762B1/en active Active
- 2013-06-14 WO PCT/IB2013/054888 patent/WO2013186754A2/en not_active Ceased
- 2013-06-14 BR BR112014031370-9A patent/BR112014031370B1/pt active IP Right Grant
- 2013-06-14 AU AU2013276084A patent/AU2013276084B2/en active Active
- 2013-06-14 ES ES13747516.6T patent/ES2659469T3/es active Active
- 2013-06-14 MX MX2014015130A patent/MX357697B/es active IP Right Grant
- 2013-06-14 CA CA2875919A patent/CA2875919C/en active Active
- 2013-06-14 KR KR1020157000638A patent/KR102065053B1/ko active Active
2014
- 2014-12-12 CL CL2014003377A patent/CL2014003377A1/es unknown

Also Published As

Publication number	Publication date
CA2875919A1 (en)	2013-12-19
KR102065053B1 (ko)	2020-01-10
JP6166365B2 (ja)	2017-07-19
CA2875919C (en)	2021-08-31
WO2013186754A3 (en)	2014-02-20
MX357697B (es)	2018-07-19
WO2013186754A2 (en)	2013-12-19
CN104619860B (zh)	2018-01-30
BR112014031370A2 (pt)	2017-07-25
US10190175B2 (en)	2019-01-29
CL2014003377A1 (es)	2015-08-07
EP2674501A1 (en)	2013-12-18
MX2014015130A (es)	2015-08-06
AU2013276084A8 (en)	2015-02-12
EP2861762A2 (en)	2015-04-22
CN104619860A (zh)	2015-05-13
AU2013276084B2 (en)	2019-04-04
KR20150030783A (ko)	2015-03-20
US20150176064A1 (en)	2015-06-25
JP2015519075A (ja)	2015-07-09
EP2861762B1 (en)	2017-12-13
AU2013276084A1 (en)	2015-01-29
BR112014031370B1 (pt)	2022-06-07

Publication	Publication Date	Title
ES2659469T3 (es)	2018-03-15	Método para detectar e identificar Escherichia Coli enterohemorrágica
US10724106B2 (en)	2020-07-28	Method for determining the presence of diarrhoea causing pathogens
You et al.	2008	A novel DNA microarray for rapid diagnosis of enteropathogenic bacteria in stool specimens of patients with diarrhea
ES2614811T3 (es)	2017-06-02	Un ensayo para determinar una evaluación del riesgo molecular de una muestra polimicrobiana compleja sospechosa de contener un EHEC
Michel et al.	2009	Genetic profiles of Shiga toxin and intimin genes found in stool broth cultures: a 2-year reference laboratory study
Moore et al.	2009	Molecular characterisation of the rec A locus in clinical isolates of verocytotoxigenic E. coli O157: H7
Verstraete	2011	Detection, isolation and typing of Shiga toxin producing (STEC) O26, O103, O111, O145, and O157 in cattle faeces, food and humans